Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | SMAD5 |
| Upstream (Parents) |
|---|
| (<<) ADAM12 → SMAD5 |
| (<<) ARL4C → SMAD5 |
| (<<) CD83 → SMAD5 |
| (<<) CDK7 → SMAD5 |
| (<<) CDKN2A → SMAD5 |
| (<<) CSNK1A1 → SMAD5 |
| (<<) CYB5R3 → SMAD5 |
| (<<) EGFR → SMAD5 |
| (<<) ELF1 → SMAD5 |
| (<<) FZD8 → SMAD5 |
| (<<) GDF15 → SMAD5 |
| (<<) GNAS → SMAD5 |
| (<<) HMGA2 → SMAD5 |
| (<<) KHDRBS3 → SMAD5 |
| (<<) KRT1 → SMAD5 |
| (<<) MAL → SMAD5 |
| (<<) MAPKAP1 → SMAD5 |
| (<<) MPP1 → SMAD5 |
| (<<) MYC → SMAD5 |
| (<<) NRIP1 → SMAD5 |
| (<<) PDPK1 → SMAD5 |
| (<<) PLCB3 → SMAD5 |
| (<<) PLCG2 → SMAD5 |
| (<<) PRKCB → SMAD5 |
| (<<) RAB15 → SMAD5 |
| (<<) RAB5B → SMAD5 |
| (<<) RPL26L1 → SMAD5 |
| (<<) RPL35 → SMAD5 |
| (<<) SLC16A6 → SMAD5 |
| (<<) SMAD2 → SMAD5 |
| (<<) STK17B → SMAD5 |
| (<<) SULT2B1 → SMAD5 |
| (<<) TEX10 → SMAD5 |
| (<<) VEGFA → SMAD5 |
| Downstream (Children) |
|---|
| SMAD5 → ADORA2B (>>) |
| SMAD5 → ARHGAP10 (>>) |
| SMAD5 → CDC42 (>>) |
| SMAD5 → CRCT1 (>>) |
| SMAD5 → DHX9 (>>) |
| SMAD5 → EPHB6 (>>) |
| SMAD5 → GALR3 (>>) |
| SMAD5 → GNA15 (>>) |
| SMAD5 → GPR153 (>>) |
| SMAD5 → HIST3H3 (>>) |
| SMAD5 → KHDRBS1 (>>) |
| SMAD5 → KRT34 (>>) |
| SMAD5 → KRT75 (>>) |
| SMAD5 → PLD1 (>>) |
| SMAD5 → PPP2R5B (>>) |
| SMAD5 → RAB22A (>>) |
| SMAD5 → SGSH (>>) |
| SMAD5 → UBE2D2 (>>) |
